Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Glauser

Showing results (121-130 of 243) with videos related to

Pageof 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1994
Pathogenesis and potential strategies for prevention and treatment of septic shock: an updateM P Glauser, D Heumann, J D Baumgartner, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1989
Diagnosis of pulmonary infections in patients infected with the human immunodeficiency virusJ P Chave, J Bille, M P Glauser, et al.
Circulation|January 1, 1988
Antibiotic prophylaxis of experimental endocarditis after dental extractionsR Malinverni, C D Overholser, J Bille, et al.
Lancet (London, England)|September 21, 1991
Septic shock: pathogenesisM P Glauser, G Zanetti, J D Baumgartner, et al.
Revue Medicale De La Suisse Romande|November 1, 1990
[Management of persons infected with HIV by medical practitioners in the canton of Vaud]G Meystre-Agustoni, J Martin, M P Glauser, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditisJ M Entenza, J Vouillamoz, M P Glauser, et al.
Progress in Clinical and Biological Research|January 1, 1995
Contribution of lipopolysaccharide binding protein (LBP) in endotoxemic shock in miceD Heumann, P Gallay, D Le Roy, et al.
The Journal of Infectious Diseases|July 1, 1994
Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidisJ M Entenza, U Fluckiger, M P Glauser, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500J M Entenza, H Drugeon, M P Glauser, et al.
The Journal of Infectious Diseases|April 1, 1991
Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5J D Baumgartner, D Heumann, T Calandra, et al.
Pageof 25

Showing results (121-130 of 243) with videos related to

Sort By:
Pageof 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1994
Pathogenesis and potential strategies for prevention and treatment of septic shock: an updateM P Glauser, D Heumann, J D Baumgartner, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1989
Diagnosis of pulmonary infections in patients infected with the human immunodeficiency virusJ P Chave, J Bille, M P Glauser, et al.
Circulation|January 1, 1988
Antibiotic prophylaxis of experimental endocarditis after dental extractionsR Malinverni, C D Overholser, J Bille, et al.
Lancet (London, England)|September 21, 1991
Septic shock: pathogenesisM P Glauser, G Zanetti, J D Baumgartner, et al.
Revue Medicale De La Suisse Romande|November 1, 1990
[Management of persons infected with HIV by medical practitioners in the canton of Vaud]G Meystre-Agustoni, J Martin, M P Glauser, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditisJ M Entenza, J Vouillamoz, M P Glauser, et al.
Progress in Clinical and Biological Research|January 1, 1995
Contribution of lipopolysaccharide binding protein (LBP) in endotoxemic shock in miceD Heumann, P Gallay, D Le Roy, et al.
The Journal of Infectious Diseases|July 1, 1994
Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidisJ M Entenza, U Fluckiger, M P Glauser, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500J M Entenza, H Drugeon, M P Glauser, et al.
The Journal of Infectious Diseases|April 1, 1991
Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5J D Baumgartner, D Heumann, T Calandra, et al.
Pageof 25